• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Blood cell folate concentration may accurately predict neural tube defects

byMia KanakandRavi Shah
July 30, 2014
in Chronic Disease, Neurology, Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Red blood cell (RBC) folate concentration from maternal serum was used to predict the incidence of neural tube defects in a population and to assess the impact of folic acid food fortification programs. 

2. The greatest reduction in risk of neural tube defects was achieved when a woman’s RBC folate concentration during pregnancy is between 1000-1300 nmol/L. 

Evidence Rating Level:  2 (Good)      

Study Rundown: Multiple studies have shown that increased maternal folic acid intake before and during pregnancy reduces the risk of neural tube defects. Unfortunately, it is difficult to estimate fetal exposure to folic acid using recall of maternal dietary intake or using plasma folate levels, which are only short-term measures of blood folate concentration. This study aimed to substantiate a more reliable measure of folic acid intake, red blood cell (RBC) folate concentration, and determine an optimal level to reduce the risk of neural tube defects. The authors applied a Bayesian model to data from two Chinese population-based studies in which women received folic acid supplementation before and during pregnancy. They found an inverse dose-response relationship between RBC folate concentration and risk of neural tube defects. They also determined that RBC folate concentration between 1000-1300 nmol/L achieves optimal prevention of neural tube defects.

The study boasts a large sample size, results consistent with those observed by in a previous study of Irish women, and the ability to accurately model the prevalence of neural tube defects in the US population before and after mandatory folic acid fortification. However, a limitation is that maternal RBC folate concentration for one of the Chinese studies was estimated based on reported pill consumption instead of actual measurements. This study adds to the literature by confirming that RBC folate concentration is directly related to rates of neural tube defects, and that an optimal threshold for RBC folate concentration (1000 nmol/L) can be used a biomarker to develop and monitor population-based folic acid fortification programs.

Click to read the study, published today in the BMJ

Click to read an accompanying editorial in the BMJ

RELATED REPORTS

Elevated maternal red blood cell folate is associated with reduced risk of congenital heart disease

Aberrant levels of B12 and folate may be associated with increased risk of cardiovascular death in patients with diabetes

Wellness Check: Nutrition

Relevant Reading: Folate levels and neural tube defects: implications for prevention

In-Depth [outcomes analysis]: The authors used data on folic acid intake and neural tube defects from two Chinese population based studies in which women received folic acid supplementation before and during pregnancy to establish a quantitative relationship between RBC folate concentration and risk of neural tube defects. The first Chinese study was a community intervention project in 1993-95 in which 247, 831 Chinese women received 400 micrograms of folic acid supplementation daily before and during their early pregnancy. The second study was a randomized clinical trial of folic acid supplementation in 2003-05 in which 1,194 Chinese women were assigned to different dosages of folic acid (100-4000μg/day). Red blood cell folate concentration data from the randomized clinical trial was used to estimate RBC folate concentration levels for participants in the first trial based on their reported pill consumption. A Bayesian model was applied and a dose-response relationship between RBC folate concentration and risk of neural tube defects was found. Specifically, compared to 25.4 neural tube defects per 10,000 births at an RBC folate concentration of 500 nmol/L, there were only 6 neural tube defects per 10,000 births at RBC folate concentrations above 1,000 nmol/L. RBC folate concentration between 1000-1300 nmol/L achieved optimal prevention of neural tube defects. The authors applied the model to the United States population using published RBC folate distributions before and after folic acid fortification and were able to accurately model the prevalence of neural tube defects.

More from this author: Unhealthy food cues prominent in children’s programming in the UK and Ireland 

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: folateneural tube defects
Previous Post

Ezetimibe (Zetia, Vytorin) use declining after ENHANCE trial publication in 2008

Next Post

Novel malaria drug clears parasitemia in phase 2 study

RelatedReports

Maternal vaccination during pregnancy not associated with infant hospitalization, mortality
Cardiology

Elevated maternal red blood cell folate is associated with reduced risk of congenital heart disease

September 1, 2022
Cardiology

Aberrant levels of B12 and folate may be associated with increased risk of cardiovascular death in patients with diabetes

April 4, 2022
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets
Wellness

Wellness Check: Nutrition

March 31, 2022
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]
Obstetrics and Gynecology Classics

Periconceptional folic acid for prevention of neural tube defects [Classics Series]

February 9, 2016
Next Post
Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

Novel malaria drug clears parasitemia in phase 2 study

Prophylactic platelet transfusions prevent bleeding in hematologic cancers

Predictors of successful transplantation for severe combined immunodeficiency

Malarial transmission substantially reduced in endemic Africa

Gene mutation associated with antimalarial resistance across Southeast Asia

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options